Winter Garden: Start Prostate Cancer Screening Now

Men in Winter Garden and throughout Central Florida should understand when to begin prostate cancer screening to maintain their health. Prostate cancer is the second most common cancer among U.S. men, and early detection significantly improves treatment outcomes.

Screening checks for cancer before symptoms appear. The prostate, a gland below the bladder, can develop cancer that often grows slowly and may not cause problems for years. Detecting abnormal cells early, while still confined to the gland, greatly enhances the chances of successful treatment.

Standard screening uses two primary tools: the PSA (prostate-specific antigen) blood test and the Digital Rectal Exam (DRE). The PSA test measures PSA, a protein produced by prostate cells. Elevated PSA levels can indicate a problem, but do not automatically confirm cancer; infections or an enlarged prostate can also raise levels. While a PSA below 4.0 ng/mL is often considered normal, a significant jump in levels warrants attention. The PSA test is simple but cannot confirm cancer alone, often requiring follow-up imaging or a biopsy.

The DRE involves a doctor feeling the prostate for abnormalities with a gloved finger. While some guidelines de-emphasize the DRE as a standalone tool, many urologists still use it alongside the PSA test for a more comprehensive assessment. This combined approach is standard practice.

For men with no family history of prostate cancer and no known genetic mutations, guidelines vary. The American Cancer Society recommends starting a conversation with a doctor at age 50. If screening begins, a PSA test, with or without a DRE, is advised. If the initial PSA is below 2.5 ng/mL, screening every two years may be reasonable; annual testing is recommended if it is 2.5 ng/mL or higher.

The U.S. Preventive Services Task Force (USPSTF) suggests men aged 55 to 69 make an individual decision about PSA-based screening after discussing potential benefits and harms with their clinician. The USPSTF recommends against routine screening for men aged 70 and older.

Certain factors can necessitate earlier screening. Men with a first-degree relative (father, brother, son) diagnosed with prostate cancer before age 65 should begin discussing screening with their doctor between ages 40 and 45. Men with two or more first-degree relatives diagnosed with the cancer face increased urgency. Inherited mutations in BRCA1 and BRCA2 genes also significantly raise prostate cancer risk; a 2024 study confirmed men with BRCA2 mutations have roughly double the lifetime risk.

Black men in the United States are approximately 70% more likely to be diagnosed with prostate cancer, a disparity that also influences screening recommendations, often suggesting earlier conversations with healthcare providers.

Winter Garden residents should understand insurance coverage or available discount programs, especially those on tight budgets or without insurance. Community Health Centers across Orange and Lake Counties can provide referrals for genetic counseling if family history is a concern. Discussing these guidelines and personal risk factors with a healthcare provider is the essential first step toward informed decision-making about prostate cancer screening.